INVESTING IN THE AGE OF LONGEVITY
2019 – 2021
We are on the verge of a lifespan revolution. In the next 30 years, life expectancy is going to rise to between 110 and 120.
The nascent but rapidly growing longevity industry has the capacity to change forever how we live, and how (and when) we die. Crucially, it will also influence how we successfully invest for the future.
At Master Investor’s Investing in the Age of Longevity events, some of the leading minds in this emerging sector mingled with the world’s most important institutional and private investors to discuss the birth of a new industry – arguably the greatest investment opportunity of all time.
Watch a 2-minute highlights video of the 2021 event.
The Geroscience Promise: The Biology of Age-Related Disease and The Potential of Therapeutic Interventions
The aged immune system – a central driver of ageing
(NB: for reasons of copyright, confidentiality and compliance, some aspects of this deck have been edited to differ from that delivered live at the event.)
Prometheus Unbound: From Myth to the Clinical Rea- lity of Organ Regeneration
Cambrian Bio – Creating longevity drugs at scale
Juvenescence: Re-imagine a Lifetime
Phil Newman, Greg Bailey and James Peyer
Dr Geoff Mullan
We love longevity, but my heart’s in healthspan
A path to safe cellular rejuvenation
Crossing the chasm: priming the market for longevity interventions
A Healthy Brain for Life
AFAR Think Tanks Report Findings
Targeting Aging with Metformin (TAME): A Concrete Plan to Pave the Way for Targeting Aging
Jim Mellon, James Peyer, Mehmood Khan and Kristen Fortney
Rejuvenating and uniting the industry to target health span and life span
The Opportunity for Investors
The progress being made in extending life- and health-spans represents both a challenge and an opportunity. How can we ensure our investments see us comfortably through an extended life and how can we capitalise on the huge financial possibilities that successful treatments for aging would present? This panel brings together three of the leading investors in the field of Longevity to discuss the opportunities and potential pitfalls.
The Science of Ageing
We are on the cusp of a revolution in our understanding of the causes and consequences of aging. As aging research gathers pace, this panel discussion brings together some of the leading experts in the field of gerontology to discuss the cutting edge scientific work being done to advance the fight against aging.
Watch a 2-minute highlights video of the 2019 event.
Dr Aubrey de Grey
Rejuvenation Biotechnology: on track to be the biggest industry ever
Unlocking the secrets of longevity
Health in the Age of Longevity
Gene Therapies to Reverse Immunosenescence and Atherosclerosis
Treating Ageing with Gene Therapy
Five Alarm Bio
7 Signs of Longevity Revolution
Younger for Longer